Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Balance Sheet

PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Balance Sheet History

[Consolidated]

Mar2023Mar2022Mar2021
EQUITY AND LIABILITIES
Share Capital ₹1,193 Cr₹1,186 Cr₹995 Cr
    Equity - Authorised ₹2,629 Cr₹1,500 Cr₹1,500 Cr
    Equity - Issued ₹1,193 Cr₹1,186 Cr₹995 Cr
    Equity Paid Up ₹1,193 Cr₹1,186 Cr₹995 Cr
    Equity Shares Forfeited ---
    Adjustments to Equity ---
    Preference Capital Paid Up ---
    Face Value ₹10.00₹10.00₹10.00
Share Warrants & Outstandings --₹0.10 Cr
Total Reserves ₹5,580 Cr₹5,511 Cr₹4,610 Cr
    Securities Premium ₹3,819 Cr₹3,725 Cr₹3,249 Cr
    Capital Reserves ₹407 Cr₹407 Cr₹407 Cr
    Profit & Loss Account Balance ₹956 Cr₹1,159 Cr₹833 Cr
    General Reserves ---
    Other Reserves ₹398 Cr₹220 Cr₹122 Cr
Reserve excluding Revaluation Reserve ₹5,580 Cr₹5,511 Cr₹4,610 Cr
Revaluation reserve ---
Shareholder's Funds ₹6,774 Cr₹6,697 Cr₹5,605 Cr
Minority Interest ---
Long-Term Borrowings ---
Secured Loans ₹3,384 Cr₹2,622 Cr₹2,339 Cr
    Non Convertible Debentures ₹399 Cr₹199 Cr-
    Converible Debentures & Bonds ---
    Packing Credit - Bank ---
    Inter Corporate & Security Deposit ---
    Term Loans - Banks ₹294 Cr₹278 Cr₹35 Cr
    Term Loans - Institutions ₹2,691 Cr₹2,145 Cr₹2,304 Cr
    Other Secured ---
Unsecured Loans ---
    Fixed Deposits - Public ---
    Loans and advances from subsidiaries ---
    Inter Corporate Deposits (Unsecured) ---
    Foreign Currency Convertible Notes ---
    Long Term Loan in Foreign Currency ---
    Loans - Banks ---
    Loans - Govt. ---
    Loans - Others ---
    Other Unsecured Loan ---
Deferred Tax Assets / Liabilities ₹-130 Cr₹-105 Cr₹-22 Cr
    Deferred Tax Assets ₹465 Cr₹406 Cr₹285 Cr
    Deferred Tax Liability ₹335 Cr₹301 Cr₹263 Cr
Other Long Term Liabilities ₹282 Cr₹240 Cr₹236 Cr
Long Term Trade Payables ---
Long Term Provisions ₹276 Cr₹145 Cr₹6.78 Cr
Total Non-Current Liabilities ₹3,812 Cr₹2,903 Cr₹2,560 Cr
Current Liabilities ---
Trade Payables ₹1,193 Cr₹1,026 Cr₹918 Cr
    Sundry Creditors ₹1,193 Cr₹1,026 Cr₹918 Cr
    Acceptances ---
    Due to Subsidiaries- Trade Payables ---
Other Current Liabilities ₹1,305 Cr₹1,243 Cr₹1,141 Cr
    Bank Overdraft / Short term credit ---
    Advances received from customers ₹201 Cr₹185 Cr₹72 Cr
    Interest Accrued But Not Due ---
    Share Application Money ---
    Current maturity of Debentures & Bonds ---
    Current maturity - Others ---
    Other Liabilities ₹1,104 Cr₹1,058 Cr₹1,069 Cr
Short Term Borrowings ₹1,302 Cr₹659 Cr₹361 Cr
    Secured ST Loans repayable on Demands ₹1,295 Cr₹617 Cr₹259 Cr
    Working Capital Loans- Sec ₹1,295 Cr₹617 Cr₹259 Cr
    Buyers Credits - Unsec ---
    Commercial Borrowings- Unsec ---
    Other Unsecured Loans ₹-1,287 Cr₹-575 Cr₹-157 Cr
Short Term Provisions ₹51 Cr₹190 Cr₹172 Cr
    Proposed Equity Dividend ---
    Provision for Corporate Dividend Tax ---
    Provision for Tax ₹12 Cr₹156 Cr₹140 Cr
    Provision for post retirement benefits --₹32 Cr
    Preference Dividend ---
    Other Provisions ₹39 Cr₹34 Cr-
Total Current Liabilities ₹3,851 Cr₹3,118 Cr₹2,591 Cr
Total Liabilities ₹14,437 Cr₹12,717 Cr₹10,756 Cr
ASSETS
Gross Block ₹10,878 Cr₹9,510 Cr₹8,173 Cr
Less: Accumulated Depreciation ₹3,409 Cr₹2,631 Cr₹2,068 Cr
Less: Impairment of Assets ---
Net Block ₹7,469 Cr₹6,879 Cr₹6,105 Cr
Lease Adjustment A/c ---
Capital Work in Progress ₹853 Cr₹673 Cr₹400 Cr
Non Current Investments ₹212 Cr₹217 Cr₹123 Cr
Long Term Investment ₹212 Cr₹217 Cr₹123 Cr
    Quoted ---
    Unquoted ₹212 Cr₹217 Cr₹123 Cr
Long Term Loans & Advances ₹494 Cr₹297 Cr₹152 Cr
Other Non Current Assets ₹0.04 Cr₹0.04 Cr₹0.04 Cr
Total Non-Current Assets ₹9,593 Cr₹8,565 Cr₹7,007 Cr
Current Assets Loans & Advances ---
Currents Investments ₹427 Cr₹50 Cr-
    Quoted ₹413 Cr₹37 Cr-
    Unquoted ₹14 Cr₹13 Cr-
Inventories ₹1,681 Cr₹1,389 Cr₹1,232 Cr
    Raw Materials ₹728 Cr₹599 Cr₹449 Cr
    Work-in Progress ₹335 Cr₹322 Cr₹318 Cr
    Finished Goods ₹247 Cr₹98 Cr₹133 Cr
    Packing Materials ---
    Stores Ā and Spare ₹172 Cr₹123 Cr₹78 Cr
    Other Inventory ₹199 Cr₹246 Cr₹254 Cr
Sundry Debtors ₹1,799 Cr₹1,785 Cr₹1,575 Cr
    Debtors more than Six months ₹127 Cr₹86 Cr-
    Debtors Others ₹1,775 Cr₹1,754 Cr₹1,622 Cr
Cash and Bank ₹308 Cr₹329 Cr₹406 Cr
    Cash in hand ₹2.21 Cr₹0.09 Cr₹0.13 Cr
    Balances at Bank ₹305 Cr₹306 Cr₹405 Cr
    Other cash and bank balances -₹22 Cr-
Other Current Assets ₹140 Cr₹94 Cr₹141 Cr
    Interest accrued on Investments --₹0.16 Cr
    Interest accrued on Debentures ---
    Deposits with Government ---
    Interest accrued and or due on loans ₹2.20 Cr₹0.29 Cr-
    Prepaid Expenses ₹77 Cr₹70 Cr₹63 Cr
    Other current_assets ₹61 Cr₹24 Cr₹78 Cr
Short Term Loans and Advances ₹488 Cr₹505 Cr₹396 Cr
    Advances recoverable in cash or in kind ₹146 Cr₹156 Cr₹121 Cr
    Advance income tax and TDS ₹7.99 Cr₹85 Cr₹100 Cr
    Amounts due from directors ---
    Due From Subsidiaries ---
    Inter corporate deposits ---
    Corporate Deposits ---
    Other Loans & Advances ₹334 Cr₹264 Cr₹174 Cr
Total Current Assets ₹4,843 Cr₹4,152 Cr₹3,749 Cr
Net Current Assets (Including Current Investments) ₹992 Cr₹1,034 Cr₹1,158 Cr
Miscellaneous Expenses not written off ---
Total Assets ₹14,437 Cr₹12,717 Cr₹10,756 Cr
Contingent Liabilities ₹57 Cr₹45 Cr₹30 Cr
Total Debt ₹5,505 Cr₹4,023 Cr₹2,910 Cr
Book Value 56.7656.4756.35
Adjusted Book Value 56.7656.4756.35

Compare Balance Sheet of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹20,419.0 Cr 2.9% 9.1% 105.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹366,103.0 Cr 0.7% -4.8% 57.3% Stock Analytics
CIPLA ₹114,230.0 Cr 1.9% -2.4% 42.6% Stock Analytics
DIVIS LABORATORIES ₹103,916.0 Cr 0.1% 3% 12.1% Stock Analytics
ZYDUS LIFESCIENCES ₹99,939.2 Cr 1.3% 0.5% 87.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,732.2 Cr -5.4% -4.1% 20% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.9%

9.1%

105.8%

SENSEX

-1.5%

-2.6%

17.8%


You may also like the below Video Courses